Yanbian University HospitaltislelizumabAdjuvant immunotherapyhepatocellular carcinomaBCLCHCC
…dy was approved by the Medical Research Ethics Committee of the Yanbian University Hospital (No. 20250006). The findings of this study will be submitted fo…